UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021		24,592,098
Beginning balance at Dec. 31, 2021	$ 1,713,990	$ 246	$ 1,529,969	$ 174,572	$ 9,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	10,597		10,597
Issuance of restricted stock, net (in shares)		438,206
Issuance of restricted stock, net	(2,778)	$ 4	(2,782)
Repurchase of common stock (in shares)		(393,036)
Repurchase of common stock	(24,972)	$ (4)	(24,275)	(693)
Common stock dividends	(29,953)			(29,953)
Foreign currency translation adjustment	(36,506)				(36,506)
Unrealized (losses) gains on marketable securities, net of tax	(706)				(706)
Net income	22,249			22,249
Ending balance (in shares) at Jun. 30, 2022		24,637,268
Ending balance at Jun. 30, 2022	1,651,921	$ 246	1,513,509	166,175	(28,009)
Beginning balance (in shares) at Mar. 31, 2022		24,963,542
Beginning balance at Mar. 31, 2022	1,724,313	$ 250	1,528,328	166,550	29,185
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,529		5,529
Issuance of restricted stock, net (in shares)		260
Issuance of restricted stock, net	(34)	$ (1)	(33)
Repurchase of common stock (in shares)		(326,534)
Repurchase of common stock	(21,011)	$ (3)	(20,315)	(693)
Common stock dividends	(14,902)			(14,902)
Foreign currency translation adjustment	(57,005)				(57,005)
Unrealized (losses) gains on marketable securities, net of tax	(189)				(189)
Net income	15,220			15,220
Ending balance (in shares) at Jun. 30, 2022		24,637,268
Ending balance at Jun. 30, 2022	1,651,921	$ 246	1,513,509	166,175	(28,009)
Beginning balance (in shares) at Dec. 31, 2022		24,402,891
Beginning balance at Dec. 31, 2022	1,635,790	$ 244	1,510,924	159,690	(35,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	11,125		11,125
Exercise of stock options, net (in shares)		1,322
Exercise of stock options, net	55		55
Issuance of restricted stock, net (in shares)		190,531
Issuance of restricted stock, net	(5,019)	$ 2	(5,021)
Repurchase of common stock (in shares)		(129,073)
Repurchase of common stock	(10,013)	$ (1)	(8,006)	(2,006)
Common stock dividends	(29,519)			(29,519)
Foreign currency translation adjustment	(16,162)				(16,162)
Unrealized (losses) gains on marketable securities, net of tax	146				146
Net income	12,203			12,203
Ending balance (in shares) at Jun. 30, 2023		24,465,671
Ending balance at Jun. 30, 2023	1,598,606	$ 245	1,509,077	140,368	(51,084)
Beginning balance (in shares) at Mar. 31, 2023		24,591,375
Beginning balance at Mar. 31, 2023	1,610,429	$ 246	1,511,590	142,893	(44,300)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,493		5,493
Issuance of restricted stock, net (in shares)		3,369
Issuance of restricted stock, net	0
Repurchase of common stock (in shares)		(129,073)
Repurchase of common stock	(10,013)	$ (1)	(8,006)	(2,006)
Common stock dividends	(14,750)			(14,750)
Foreign currency translation adjustment	(6,822)				(6,822)
Unrealized (losses) gains on marketable securities, net of tax	38				38
Net income	14,231			14,231
Ending balance (in shares) at Jun. 30, 2023		24,465,671
Ending balance at Jun. 30, 2023	$ 1,598,606	$ 245	$ 1,509,077	$ 140,368	$ (51,084)